Page last updated: 2024-11-03

propafenone and Genetic Predisposition

propafenone has been researched along with Genetic Predisposition in 2 studies

Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bjerregaard, P1
Gussak, I1
Lehtonen, A1
Fodstad, H1
Laitinen-Forsblom, P1
Toivonen, L1
Kontula, K1
Swan, H1

Reviews

1 review available for propafenone and Genetic Predisposition

ArticleYear
Short QT syndrome: mechanisms, diagnosis and treatment.
    Nature clinical practice. Cardiovascular medicine, 2005, Volume: 2, Issue:2

    Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Death, Sudden, Cardiac; Electric Countershock; Electroc

2005

Other Studies

1 other study available for propafenone and Genetic Predisposition

ArticleYear
Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug-associated torsades de pointes.
    Heart rhythm, 2007, Volume: 4, Issue:5

    Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; DNA Mutational Analysis; Electrocardiog

2007